Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1253

1.

Bilateral uveal melanoma: hunting for the source.

Shields CL, Masoomian B, Shields JA.

Clin Exp Ophthalmol. 2018 Jul;46(5):459-461. doi: 10.1111/ceo.13344. No abstract available.

PMID:
30003677
2.

GROWTH OF PRESUMED CHOROIDAL NEVUS INTO MELANOMA OVER 4 YEARS IN BAP1 TUMOR PREDISPOSITION SYNDROME.

Masoomian B, Shields CL, Mashayekhi A, Ganguly A, Shields JA.

Retin Cases Brief Rep. 2018 Jul 6. doi: 10.1097/ICB.0000000000000772. [Epub ahead of print]

PMID:
29994997
3.

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma.

Masoomian B, Shields JA, Shields CL.

J Curr Ophthalmol. 2018 Mar 22;30(2):102-109. doi: 10.1016/j.joco.2018.02.005. eCollection 2018 Jun. Review.

4.

Distinguishing midzonal iris pigment epithelial cyst from adenoma and ciliary body melanoma.

Mayro EL, Surakiatchanukul T, Shields JA, Shields CL.

Oman J Ophthalmol. 2018 May-Aug;11(2):161-163. doi: 10.4103/ojo.OJO_226_2017.

5.

Advanced Midzonal Iris Pigment Epithelial Cyst Managed by Aspiration Deflation.

Shields JA, Fallon SJ, Shields CN, Lally SE, Shields CL.

Ocul Oncol Pathol. 2018 Apr;4(3):182-185. doi: 10.1159/000481405. Epub 2017 Nov 9.

PMID:
29765951
6.

Cytogenetic results of choroidal nevus growth into melanoma in 55 consecutive cases.

Shields CL, Pefkianaki M, Mashayekhi A, Shields JA, Ganguly A.

Saudi J Ophthalmol. 2018 Jan-Mar;32(1):28-32. doi: 10.1016/j.sjopt.2018.02.004. Epub 2018 Feb 15.

7.

CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects.

Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA.

Retina. 2018 Jun;38(6):1063-1078. doi: 10.1097/IAE.0000000000002181. Review.

PMID:
29689030
8.

By Sleight of Hand, Prognosis Determined-Even for Small Choroidal Melanoma.

Shields CL, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2018 May 1;136(5):488-489. doi: 10.1001/jamaophthalmol.2018.0196. No abstract available.

PMID:
29596557
9.

Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases.

Dalvin LA, Shields CL, Pulido JS, Sioufi K, Cohen V, Shields JA.

JAMA Ophthalmol. 2018 May 1;136(5):543-547. doi: 10.1001/jamaophthalmol.2018.0554.

10.

LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture.

Shields CL, Sioufi K, Robbins JS, Barna LE, Harley MR, Lally SE, Say EAT, Mashayekhi A, Shields JA.

Retina. 2018 Mar 8. doi: 10.1097/IAE.0000000000002144. [Epub ahead of print]

PMID:
29528980
11.

Caruncular Oncocytoma Mimicking Malignant Melanoma.

Surakiatchanukul T, Sioufi K, Pointdujour-Lim R, Eagle RC Jr, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Nov;3(4):320-323. doi: 10.1159/000468524. Epub 2017 May 6.

PMID:
29344489
12.

Intravitreal Aflibercept as Rescue Therapy for Post-Radiation Cystoid Macular Edema Resistant to Intravitreal Bevacizumab: Outcomes at 1 Year.

Khan MA, Mashayekhi A, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Nov;3(4):313-319. doi: 10.1159/000452163. Epub 2017 May 6.

13.

Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.

Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, Shields JA.

Ophthalmology. 2018 Jun;125(6):913-923. doi: 10.1016/j.ophtha.2017.11.040. Epub 2018 Jan 17.

PMID:
29342436
14.

INVISIBLE, HONEYCOMB-LIKE, CAVITARY RETINAL ASTROCYTIC HAMARTOMA.

Mellen PL, Sioufi K, Shields JA, Shields CL.

Retin Cases Brief Rep. 2017 Dec 28. doi: 10.1097/ICB.0000000000000697. [Epub ahead of print]

PMID:
29286955
15.

Optical coherence tomography angiography of iris microhemangiomatosis.

Kang AS, Welch RJ, Sioufi K, Say EAT, Shields JA, Shields CL.

Am J Ophthalmol Case Rep. 2017 Feb 13;6:24-26. doi: 10.1016/j.ajoc.2017.02.003. eCollection 2017 Jun.

16.

High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema.

Khan MA, Mashayekhi A, Ferguson K, Shields JA, Shields CL.

Ocul Oncol Pathol. 2017 Sep;3(3):168-175. doi: 10.1159/000448719. Epub 2017 Jan 27.

17.

Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture.

Shields CL, Roelofs K, Di Nicola M, Sioufi K, Mashayekhi A, Shields JA.

Indian J Ophthalmol. 2017 Nov;65(11):1093-1104. doi: 10.4103/ijo.IJO_752_17.

18.

Mantle-Cell Lymphoma-Taming the Tiger.

Shields CL, Lally SE, Shields JA.

JAMA Ophthalmol. 2017 Dec 1;135(12):1374-1375. doi: 10.1001/jamaophthalmol.2017.4290. No abstract available.

PMID:
29121204
19.

CHOROIDAL MELANOMA IN PHAKOMATOSIS PIGMENTOVASCULARIS WITH KLIPPEL-TRENAUNAY SYNDROME.

Shields CL, Di Nicola M, Pellegrini M, Shields JA.

Retina. 2017 Sep 20. doi: 10.1097/IAE.0000000000001856. [Epub ahead of print]

PMID:
28937525
20.

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.

Valsecchi ME, Orloff M, Sato R, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T.

Ophthalmology. 2018 Feb;125(2):210-217. doi: 10.1016/j.ophtha.2017.08.017. Epub 2017 Sep 19.

PMID:
28935400

Supplemental Content

Loading ...
Support Center